-+ 0.00%
-+ 0.00%
-+ 0.00%

LANTERN PHARMA INC - LP-300 DEMONSTRATES 8.3-MONTH MEDIAN PROGRESSION-FREE SURVIVAL WITH NO ADDED TOXICITY

Reuters·04/20/2026 12:07:17

Please log in to view news